VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2025)

VitaNova Life Sciences (VNOV) posted Share-based Compensation of $500.0 for Q1 2025, down 33.33% on a QoQ basis from $750.0 in Q4 2024.

VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2025) Analysis & Trends

VitaNova Life Sciences' Share-based Compensation history runs 2 years deep, the most recent figure standing at $500.0 for Q1 2025.

Quarterly Share-based Compensation changed N/A year-over-year to $500.0 in Q1 2025, while the trailing twelve-month figure through Oct 2025 was $500.0 (down 80.0% YoY) and the FY2025 annual result came in at $2000.0, up 100.0% from the prior year.
Share-based Compensation was $500.0 for Q1 2025 at VitaNova Life Sciences, down from $750.0 in the prior quarter.
Across five years, Share-based Compensation topped out at $1000.0 in Q2 2024 and bottomed at $500.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Mckesson	105.15 Bn	101.18 Bn	4.04 Bn	-
2	Cencora	60.58 Bn	58.40 Bn	3.59 Bn	28.00 Mn
3	Cardinal Health	53.81 Bn	49.87 Bn	2.50 Bn	129.00 Mn
4	Henry Schein	9.71 Bn	9.57 Bn	1.07 Bn	3.00 Mn
5	Akso Health	3.28 Bn	3.28 Bn	-	-
6	111	651.73 Mn	572.63 Mn	23.58 Mn	499,959.76
7	Accendra Health	248.02 Mn	-88.86 Mn	278.03 Mn	3.09 Mn
8	Edap Tms	230.14 Mn	215.14 Mn	8.15 Mn	302,000.00
9	VitaNova Life Sciences	11.51 Mn	11.01 Mn	316,343.00	-
10	Cosmos Health	9.57 Mn	7.41 Mn	1.38 Mn	535,786.00

Download Data